chiamare dettagli tariffa cappellini and haematologica 2017 Più di tutto Furfante Facile
Untitled
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients | Haematologica
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
Haematologica, Volume 105, Issue 10 by Haematologica - Issuu
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Recommendations regarding splenectomy in hereditary hemolytic anemias | Haematologica
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica